Fieldpoint Private Securities’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$47K Sell
1,046
-49
-4% -$2.51K 0.01% 491
2022
Q1
$62K Buy
1,095
+82
+8% +$4.28K 0.01% 527
2021
Q4
$53K Sell
1,013
-285
-22% -$14.7K 0.01% 596
2021
Q3
$78K Buy
1,298
+2
+0.2% +$126 0.02% 469
2021
Q2
$82K Sell
1,296
-90
-6% -$6K 0.02% 464
2021
Q1
$90K Buy
1,386
+328
+31% +$21.4K 0.02% 422
2020
Q4
$70K Buy
+1,058
New +$62.2K 0.02% 435
2020
Q1
Sell
-1,202
Closed -$66K 341
2019
Q4
$66K Buy
1,202
+511
+74% +$27.7K 0.02% 382
2019
Q3
$35K Buy
691
+392
+131% +$19.7K 0.01% 429
2019
Q2
$15K Buy
+299
New +$14.5K ﹤0.01% 564

Other funds holding EHC

Fieldpoint Private Securities's EHC Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Encompass Health (EHC) stake by 4.5% in Q2 2022, selling an estimated $2.51K and leaving 1,046 shares worth $47K. The position accounts for 0.01% of the portfolio, ranked #491.

Fieldpoint Private Securities first reported a position in EHC in Q2 2019 and has held it in 10 quarters since. The position peaked at $90K in Q1 2021. 394 funds tracked by Wall St. Rank hold EHC as of Q2 2022.

  • Fieldpoint Private Securities held 1,046 shares of Encompass Health worth $47K as of Q2 2022.
  • Fieldpoint Private Securities sold 49 Encompass Health shares in Q2 2022, an estimated $2.51K.
  • Encompass Health made up 0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #491 holding.
  • Fieldpoint Private Securities first reported a position in Encompass Health in Q2 2019 and has held it in 10 quarters since.
  • Fieldpoint Private Securities's Encompass Health position peaked at $90K in Q1 2021.
  • 394 funds tracked by Wall St. Rank held Encompass Health as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.